David Craig Miller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David Craig Miller has a total of 405 co-authors. Here are the top co-authors by number of shared publications:
David Liang
29 shared publicationsNeil B. Ingels
Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif; Laboratory of Cardiovascular Physiology and Biophysics, Research Institute of the Palo Alto Medical Foundation, Palo Alto, Calif
27 shared publications- Neil B IngelsJr
Laboratory of Cardiovascular Physiology and Biophysics, Research Institute of the Palo Alto Medical Foundation, Palo Alto, CA
18 shared publications George T. Daughters
Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif
16 shared publicationsWolfgang Bothe
Department of Cardiovascular Surgery, Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif
15 shared publications- John-Peder Escobar Kvitting
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
13 shared publications
Latest Publications
- 12 May 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (19) , 1520-1522
Current Incidence and Modality of Young Aortic Valve Replacement in the United States
- 12 May 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (19) , 1520-1522
Current Incidence and Modality of Young Aortic Valve Replacement in the United States
- 1 December 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 7 (6) , e240325
Reproducibility of the 2020 Society for Vascular Surgery/Society of Thoracic Surgeons Reporting Standards for Uncomplicated Type B Aortic Dissection
Allocation of key type B aortic dissection features to aortic zones, as defined by the 2020 Society for Vascular Surgery/Society of Thoracic Surgeons reporting standards, was poorly reproducible among experienced cardiovascular radiologists and surgeons.
- 1 December 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 7 (6) , e240325
Reproducibility of the 2020 Society for Vascular Surgery/Society of Thoracic Surgeons Reporting Standards for Uncomplicated Type B Aortic Dissection
Allocation of key type B aortic dissection features to aortic zones, as defined by the 2020 Society for Vascular Surgery/Society of Thoracic Surgeons reporting standards, was poorly reproducible among experienced cardiovascular radiologists and surgeons.
- 10 April 2025
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 119 (6) , 1166-1174
Expanding Transcatheter Aortic Valve Replacement Use in Younger Patients and Bicuspid Valves: Risks, Evidence Gaps, and Regulatory Action
- 10 April 2025
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 119 (6) , 1166-1174
Expanding Transcatheter Aortic Valve Replacement Use in Younger Patients and Bicuspid Valves: Risks, Evidence Gaps, and Regulatory Action
- 1 February 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 18 (2) , e016766
Predicting Late Adverse Events in Uncomplicated Stanford Type B Aortic Dissection: Results From the ROADMAP Validation Study
BACKGROUND: Risk stratification is highly desirable in patients with uncomplicated Stanford type B aortic dissection but inadequately supported by evidence. We sought to validate externally a published prediction model for late adverse events (LAEs), consisting of 1 clinical (connective tissue disease) and 4 imaging variables: maximum aortic diameter, false lumen circumferential angle, false lumen outflow, and number of identifiable intercostal arteries. METHODS: We assembled a retrospective multicenter cohort (ROADMAP [Registry of Aortic Diseases to Model Adverse Events and Progression]) of 401 patients with uncomplicated Stanford type B aortic dissection presenting to 1 of 8 aortic centers between 2001 and 2013, followed until 2020. LAEs were defined as fatal or nonfatal aortic rupture, new refractory hypertension or pain, organ or limb ischemia, aortic aneurysm formation (≥6 cm), or rapid growth (≥1 cm per year). We applied the original model parameters to the validation cohort and examined the effect on risk categorization using LAE end points. RESULTS: One hundred and seventy-six patients (44%) with incomplete imaging or clinical data were excluded. Of 225 patients in the final cohort, 90 (40%) developed LAEs, predominantly driven by aneurysm formation. Baseline maximum aortic diameter was significantly larger in patients with (42.6 [95% CI, 39.1–45.8] mm) compared with patients without LAEs (39.9 [95% CI, 36.3–44.2] mm; P =0.001). A multivariable Cox regression model indicated that only maximum diameter was associated with LAEs (hazard ratio, 1.07 [95% CI, 1.03–1.11] per mm; P 0.05). Applying the original prediction model to the validation cohort resulted in a poor 5-year sensitivity (38%) and specificity (69%). CONCLUSIONS: A clinical and imaging-based prediction model performed poorly in the ROADMAP cohort. Maximum aortic diameter remains the strongest predictor of LAEs in uncomplicated Stanford type B aortic dissection.
- 1 February 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 18 (2) , e016766
Predicting Late Adverse Events in Uncomplicated Stanford Type B Aortic Dissection: Results From the ROADMAP Validation Study
BACKGROUND: Risk stratification is highly desirable in patients with uncomplicated Stanford type B aortic dissection but inadequately supported by evidence. We sought to validate externally a published prediction model for late adverse events (LAEs), consisting of 1 clinical (connective tissue disease) and 4 imaging variables: maximum aortic diameter, false lumen circumferential angle, false lumen outflow, and number of identifiable intercostal arteries. METHODS: We assembled a retrospective multicenter cohort (ROADMAP [Registry of Aortic Diseases to Model Adverse Events and Progression]) of 401 patients with uncomplicated Stanford type B aortic dissection presenting to 1 of 8 aortic centers between 2001 and 2013, followed until 2020. LAEs were defined as fatal or nonfatal aortic rupture, new refractory hypertension or pain, organ or limb ischemia, aortic aneurysm formation (≥6 cm), or rapid growth (≥1 cm per year). We applied the original model parameters to the validation cohort and examined the effect on risk categorization using LAE end points. RESULTS: One hundred and seventy-six patients (44%) with incomplete imaging or clinical data were excluded. Of 225 patients in the final cohort, 90 (40%) developed LAEs, predominantly driven by aneurysm formation. Baseline maximum aortic diameter was significantly larger in patients with (42.6 [95% CI, 39.1–45.8] mm) compared with patients without LAEs (39.9 [95% CI, 36.3–44.2] mm; P =0.001). A multivariable Cox regression model indicated that only maximum diameter was associated with LAEs (hazard ratio, 1.07 [95% CI, 1.03–1.11] per mm; P 0.05). Applying the original prediction model to the validation cohort resulted in a poor 5-year sensitivity (38%) and specificity (69%). CONCLUSIONS: A clinical and imaging-based prediction model performed poorly in the ROADMAP cohort. Maximum aortic diameter remains the strongest predictor of LAEs in uncomplicated Stanford type B aortic dissection.
- 1 December 2022
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 4 (6) , e220039
Registry of Aortic Diseases to Model Adverse Events and Progression (ROADMAP) in Uncomplicated Type B Aortic Dissection: Study Design and Rationale
This report presents the design and methodological approach of a multicenter, retrospective study to validate a clinical and imaging-based risk prediction model for late adverse events in patients ... Purpose To describe the design and methodological approach of a multicenter, retrospective study to externally validate a clinical and imaging-based model for predicting the risk of late adverse ev...
- 1 December 2022
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 4 (6) , e220039
Registry of Aortic Diseases to Model Adverse Events and Progression (ROADMAP) in Uncomplicated Type B Aortic Dissection: Study Design and Rationale
This report presents the design and methodological approach of a multicenter, retrospective study to validate a clinical and imaging-based risk prediction model for late adverse events in patients ... Purpose To describe the design and methodological approach of a multicenter, retrospective study to externally validate a clinical and imaging-based model for predicting the risk of late adverse ev...
- 1 September 2021
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 15 (5) , 431-440
CTA pulmonary artery enlargement in patients with severe aortic stenosis: Prognostic impact after TAVR
- 1 September 2021
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 15 (5) , 431-440
CTA pulmonary artery enlargement in patients with severe aortic stenosis: Prognostic impact after TAVR
- Open Access
- 1 September 2020
- Published by Elsevier in JTCVS Techniques
- Vol. 3, 259-262
Repair of extra-anatomic bypass graft structural degeneration and pseudoaneurysm with endovascular stent-graft relining
- 1 September 2020
- Published by Elsevier in JTCVS Techniques
- Vol. 3, 259-262
Open AccessRepair of extra-anatomic bypass graft structural degeneration and pseudoaneurysm with endovascular stent-graft relining
- 1 December 2019
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 1 (5) , e190067
Incremental Value of Aortomitral Continuity Calcification for Risk Assessment after Transcatheter Aortic Valve Replacement
Aortomitral continuity calcification is a predictor of mortality within 1 year after transcatheter aortic valve replacement and, together with coronary calcium, substantially improves individual ri... Purpose To investigate the association of aortomitral continuity calcification (AMCC) with all-cause mortality, postprocedural paravalvular leak (PVL), and prolonged hospital stay in patients under...
- 1 December 2019
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 1 (5) , e190067
Incremental Value of Aortomitral Continuity Calcification for Risk Assessment after Transcatheter Aortic Valve Replacement
Aortomitral continuity calcification is a predictor of mortality within 1 year after transcatheter aortic valve replacement and, together with coronary calcium, substantially improves individual ri... Purpose To investigate the association of aortomitral continuity calcification (AMCC) with all-cause mortality, postprocedural paravalvular leak (PVL), and prolonged hospital stay in patients under...
- 1 October 2019
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 158 (4) , 1058-1068
Do annuloplasty rings designed to treat ischemic/functional mitral regurgitation alter left-ventricular dimensions in the acutely ischemic ovine heart?
- 1 October 2019
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 158 (4) , 1058-1068
Do annuloplasty rings designed to treat ischemic/functional mitral regurgitation alter left-ventricular dimensions in the acutely ischemic ovine heart?
- 1 April 2019
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 157 (4) , 1444-1449
Characterization of 3-dimensional papillary muscle displacement in in vivo ovine models of ischemic/functional mitral regurgitation
- 1 April 2019
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 157 (4) , 1444-1449
Characterization of 3-dimensional papillary muscle displacement in in vivo ovine models of ischemic/functional mitral regurgitation